Home › MEDTRONIC, INC. › MO.MA ULTRA
MO.MA ULTRA
MEDTRONIC, INC. · Model MUS0130069X6 · UDI-DI 08033477071909
NTE
Prescription
1
510(k) clearances
5,311
Adverse events (112 deaths)
30
Recalls
25
Facilities
Description
CATH MUS0130069X6 CPD ULTRA US 9F UL950
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-07-09 | Boston Scientific Corporation | Potential for arterial sheath tip separation or partial tip separation during use. |
| 2026-07-09 | Boston Scientific Corporation | Potential for arterial sheath tip separation or partial tip separation during use. |
| 2023-10-12 | Medtronic Inc | The Mo.Ma Ultra device manifold is labelled with 2 stickers, an inferior and superior sticker, one on each side of the manifold. These stickers label the common carotid artery (CCA |
| 2023-10-12 | Medtronic Inc | The Mo.Ma Ultra device manifold is labelled with 2 stickers, an inferior and superior sticker, one on each side of the manifold. These stickers label the common carotid artery (CCA |
| 2023-10-12 | Medtronic Inc | The Mo.Ma Ultra device manifold is labelled with 2 stickers, an inferior and superior sticker, one on each side of the manifold. These stickers label the common carotid artery (CCA |
| 2023-03-24 | Cordis US Corp | There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unpl |
| 2023-03-24 | Cordis US Corp | There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unpl |
| 2023-03-24 | Cordis US Corp | There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unpl |
| 2023-03-24 | Cordis US Corp | There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unpl |
| 2023-03-24 | Cordis US Corp | There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unpl |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.